Catalysts for Cadila Pharmaceuticals Ltd
21 tracked
Jan 22, 2026
approval
OLANZAPINE — FDA approval
olanzapine ODT
→
Nov 5, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Oct 23, 2025
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
May 7, 2024
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Aug 8, 2023
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Aug 8, 2023
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Feb 24, 2023
approval
OLANZAPINE — FDA approval
olanzapine ODT
→
Feb 7, 2023
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Feb 7, 2023
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Jun 13, 2022
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jan 16, 2020
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Jul 9, 2019
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→
May 24, 2016
approval
VORICONAZOLE — FDA approval
VORICONAZOLE
→